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Dementia is a collective term used to indicate a loss of memory functions with the
presence of at least one additional loss of a major cognitive ability that hinders a person’s
previous level of functioning. Studies show that dementia is highly age- associated and that the
most common cause of dementia is Alzheimer’s disease. Early recognition of Alzheimer’s disease,
before irreversible damage to the brain has already occurred, is paramount to slowing or
preventing the disease. Therefore, algorithms for the prediction of early signs of dementia are
essential. Machine learning approach has been reported to use several data sources such as
neuroimaging, biological, neuropsychological, or a combination of different biomarkers to
generate a system to predict the onset of Alzheimer’s.
This thesis introduced a Risk Monitoring System that integrates heterogeneous multisource Alzheimer’s disease data. It identified the most significant predictors in terms of the
clinical and cognitive features associated with early signs of AD. Appropriate statistical survival
analysis methods (semi- parametric and parametric methods) integrated with machine learning
approaches such as Support Vector Machine and Random Survival Forest have been investigated.

Scores from the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment
(MoCA) used in an integrated framework along with individuals’ demographic data such as age,
sex, education level and race to develop a system for prediction with higher accuracy rates than
those of current individual methods or systems.
Working with big data set, the biggest challenges is that the size of the dataset does not
guarantee the validity of the results. This thesis thus attempts to develop predicting system
focusing on the new facilities that big data offers; optimally extract information from massive
data and having inference on the factors that affect the conversion between AD stages; mild,
moderate and severe. Utilizing Big data tools helped improve the efficiency and speed of applied
algorithms, especially those that need large computation (i.e., Survival Decision Tree). The tested
algorithms (COX, SDT, and RNNs) showed a good prediction accuracy, however, RNN (LSTM and
GRU) outperforms the other two algorithms and state-of-art algorithms.
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Chapter 1

Introduction
1.1 Alzheimer’s Disease: An overview
In the late 1890s, Auguste Deter (German women) started finding a difficult time
remembering recent events. She also noticed changes in her behavior that she can't explain, as
well as problems with speaking and writing. At an institution that she attended between 1901
and 1902 there was a doctor named Dr. Alois Alzheimer interested to know more about Auguste’s
case. Dr. Alzheimer started interviewing Auguste, however, after five years (in April 1906),
Auguste passed away with no treatment for her symptom. Later in the same year, Dr. Alzheimer
concluded, after studying Auguste’s brain and medical records, that August had a rare form of
dementia that affects people under 65 of age [1].
Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disease with
insidious onset that causes problems with memory, cognition, and behavior. Symptoms of AD
develop slowly. In early stages, Alzheimer's Symptoms are difficulty remembering recent
conversations, names, or events as well as apathy and depression, but late-stages include
impaired communication, disorientation, poor judgment, behavior changes, and ultimately,
difficulty speaking, swallowing, and walking [2]. It is often using “Alzheimer's Disease” term
interchangeably with “Dementia” term; however, it is important to mention that these are two
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different terms. According to Alzheimer’s Association, “Dementia” is a general term for loss of
memory, language, problem-solving and other thinking abilities that are severe enough to
interfere with daily life, however, “Alzheimer's Disease” is the most common cause of dementia.
To put it in another way, “Dementia” is a general term for a decline in mental ability, whereas
“Alzheimer's Disease” is the most common form of “Dementia”. In addition to “Alzheimer's
Disease”, dementia includes other mental diseases - Vascular Dementia, Lewy Body Dementia
(LBD), Frontotemporal Degeneration (FTD), Parkinson's Disease Dementia, Mixed Dementia,
Huntington's Disease, Creutzfeldt-Jakob Disease, Normal Pressure Hydrocephalus, WernickeKorsakoff Syndrome [3].
As stated in Alzheimer's disease Facts and Figure report, AD is the sixth leading cause of
death in the united states. More than five million American are living with and by 2050 this
number projected to rise to nearly 14 Million. The death percentage due Alzheimer disease
increased by 145.0% from 200 to 2017, while from heart disease have decreased 7.8% (see figure
1 below). In other word, between 2000 and 2017 deaths resulting from heart disease decreased
by 8.9% whereas those from Alzheimer increased by 145.0% (the mortality rate for AD was 37.3
deaths per 100,000 people). AD kills more than breast cancer and prostate cancer combined.
Moreover, according to Chicago Health and Aging Project (CHAP) study, in 2017 an estimated
700,000 people age 65 and older in the United States will have Alzheimer’s when they die. From
the cost perspective, AD and other dementias cost $305 Billion and this cost could rise to $1.1
Trillion in 2050. In 2019, the cost of caring for more than 16 million Americans with AD and
another dementia valued at $244 billion [4].

2

Figure 1.1. Percentage changes in selected cause of death (ALL ages)
between 2000 and 2017 [4]

AD can be diagnosed using clinical assessment and neuropsychological tests and is usually
made once the disease is at an advanced stage. Heretofore, there is no effective treatment to
treat or slow the progression of the AD [3]. Therefore, earlier and accurate diagnosis would allow
providing adequate care to the patient and accurate information to the patient and their family.
AD is a brain disease where brain cells progressively degenerate. By this degeneration,
brain move from one stage to another, this process of moving called conversion or progression.
Generally, AD converts in three stages. The first stage is Clinical Normal (CN); where the subject
does not show signs of objective cognitive. The next stage is Mild Cognitive Impairment (MCI),
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where subject has score of Logical Memory subscale. Subject with MCI is at the risk of converting
to AD [5]. It is been reported that 7% of subjects with MCI convert to AD each year [6]. Subjects
with MCI can be divided into two subclasses depending on the progression of the disease.
Subjects with MCI who later convert to AD considered to progressive MCI (pMCI), whereas
subjects who have stable MCI are considered to stable MCI (sMCI). One important research field
that researchers are following is how differentiate between sMCI and pMCI in order to identify
MCI patients who are at high risk of converting to AD, so early detection of this group of patients
may help clinicians to effectively treat the condition [5].

1.2 Machine Learning Deployed for AD Prediction
Machine learning (ML) is a branch of Artificial Intelligent (AI) that concern with a wide
range of techniques and algorithms that can learn and improve without explicit programming.
Different industries can get the benefit of ML, and one of the most remarkable industries is
healthcare. In healthcare industry, an abundant health data collected from numerous sources
including electronic health records (EHRs), medical imaging, genomic sequencing, payor records
to mention a few. Hence, these data mainly have three features that make it different from
traditional data [7]. First, it is available in extraordinary high volume: the volume of global data
overall is increasing exponentially, from 130 exabytes in 2005 to 35 zettabytes in 2020. In
healthcare, increase comes from digitizing existing data and from generating new data forms.
Second feature of the data is it moves in high velocity: with the new medical situations, real-time
data from different (blood pressure monitoring system, anesthesia monitoring system, bedside
heart monitors, etc.) become a matter of life or death. This velocity refers for both the rate at
4

which the data are being collected and the necessary speed of the data analyzing and processing.
Lastly, since it come from different source, the data would be variable in structure and nature.
From what mentioned earlier, healthcare industry has been highly encouraged to embrace big
data analysis and ML to derive valuable insights to improve healthcare quality and efficiency [8].

1.3 Research Contribution and Research Questions
The main objective of this thesis is to utilize ML approaches for classifying and predicting
AD. In our work we are trying to answer the following questions:
1) “Using clinical data, to what extent can a classifier classify subjects?”
As stated in earlier, subjects can be classified into CN, MCI and AD. Furthermore,
MCI can be classified into sMCI and pMCI. We are trying to classify the subject in a
dataset into the previous subclasses such that physicians will be aware of their patients
such that they can treat each one accordingly.
2) “Can we build a machine learning model that can predict the time of conversion?”
To support the first research question, we are trying to predict the time of
conversion from one stage of AD to another.
3) “With the medical and health data reached massive volume, to what level we can
involve Big Data technologies to our previous research questions?”
To answer this question, we will discuss applying ML with big data technologies to build
classifier and predictor for AD.
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Given these points, our goal in this dissertation is to build a “Risk Monitoring System”
(RMS) that can plays as an alarm for any conversion that may be happened in near future. For
this purpose, we analyze heterogeneous and complex dataset that represents AD with different
stages, to investigate the relationship between AD stages. Our goal here is to identify symptoms
to detect AD before it is noticeable, where usually AD detected after its symptoms noticed by
some patient's relatives or friends.

1.4 Structure of the Thesis
This thesis structured as follows: Chapter two will investigate the literature review and
background information. Initially we will discuss the progression of AD in more details and
focusing on the signs that can be used for AD diagnosing. Secondly, some important concepts
that have been used in AD will be detailed some of these concepts are Clinical Dementia Rating
(CDR), Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA).
Afterwards, ML algorithms for medical and healthcare will be analyzed and explained. The
chapter will be summarized by discussing our contribution path and where we see our work
among the current path of research.
Chapter three describes how survival analysis can be applied to clinical data and what are
the factors that effect on the prediction of AD. In this we will discuss how to use MMSE in AD
prediction of AD. Also, we will discuss the pros and cons of MMSE and how we can improve this
predictivity by adding more biomarkers to the prediction system. Specifically, the work in the

6

chapter be presented on censored data. Finally, the chapter will go through the novel tests
performance and will evaluate all the used biomarkers.
Since the accuracy of ML will increased as much data that we can be feed to the ML
algorithm in testing and validation, and consequently working with large set of data will make
lake in these ML algorithm, chapter four, will be a suggestion to utilized cloud ML algorithms
(Survival Decision Tree), on clinical data. The chapter will go through the details of how Big Data
technologies can be utilized to overcome any lake that might occur when we use ML on large set
of data. As we will see in chapter three, chapter four will be summarized with discussion of the
advantages and disadvantages using decision tree in big data world and how we can improve the
applied algorithm. Moreover, the performance of the applied algorithm will be discussed.
In Chapter five, we will discuss building a prediction and classification system for the
conversion of MCI using Recurrent Neural Network (RNN). Our goal in chapter five is to build a
model to estimate the risk score and the survival function for each subject. The chapter will be
into two main parts: first part will show how we trained RNN algorithm for classification and
prediction. Afterwards, a comparison between RNN with some other ML algorithm will be
presented to presented.
Chapter six will revisit our research questions and contributions and will discuss them
with the previous works. The chapter also will point out to the general path of AD progression
and where our work in this path. Finally, in chapter seven, we will go through the summary and
conclusions and we will point out to some suggestions for future works.
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Chapter 2

Literature Review
Profusion of progress has been made in identifying and diagnosing Alzheimer's disease,
and we still have ways to go. Generally, AD has been formally identified in the beginning of last
century, while in the last 50 years, a serious advance to recognize the impact of Alzheimer's has
been made. Again, in last 20 years, more steps of recognizing and predicting AD have been taken.
Nowadays, the centerpiece of describing the clinical diagnosis of AD is still the criteria that
established in 1983 by the National Institute of Neurological and Communicative Disorders and
Stroke (NINCDS) and the Alzheimer’s Disease and Related Disorders Association (ADRDA) [1,9].
This

criterion

specified

eight

cognitive

domains

that

may

be

impaired

in

AD: memory, language, perceptual skills, attention, constructive abilities, orientation, problem
solving and functional abilities [2,5, 9-11].
In April 2011, NINCDS- ADRDA criterion has been revised by NINCDS- ADRDA to add and
update new facts. The term “possible Alzheimer’s Disease” is one of the redefined terms that the
revised criteria have. More importantly, they retained the general framework of probable AD
dementia from the 1984 criteria, you can refer to [12] for more details.
Generally, to diagnose Alzheimer’s disease, physicians may use different tests - medical
history, mental status tests, physical and neurological exams, diagnostic tests and brain imaging
[2, 13]. This thesis focuses on predicting AD progression from clinical trial using different machine
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learning. In this chapter we present relevant work related to areas such as Alzheimer's Disease
predicting and progression using clinical trial. In addition, other relevant concepts, metrics,
methodologies and techniques are addressed in accordance with the work to be presented in
subsequent chapters.

2.1 Development of Alzheimer’s disease
One of the biggest challenges that physicians are facing is that they cannot stop or
control Alzheimer’s Disease progression because the lack of knowledge on the patterns that
triggered the development of AD. Recognizing cognitive symptoms early (MCI) is a key because
medication to control symptoms is most effective in the early stages of the disease. However,
the problem is that MCI is heterogeneous condition; MCI could possibly develop into AD or other
neurodegenerative diseases, it also possible to stay stable as MCI or even revert back to the
Cognitive Normal stage [7,13,14].
The development of AD has been investigated by large number of researches. The main
gool of these researches was to discover AD development over time and to understand the
related abnormalities that take place in the brain. Also, these researches studied the patterns
of progression of multiple factors. Understanding these abnormalities and progression factors
is necessary for selecting features for predicting AD progression. AD related pathologies appear
many years before clinical onset of the disease. This means that the AD pathology develops
while the individual is still cognitively.
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There are large number of standardized screening tools that used by clinicians to
determine a person’s cognitive status. Some of these tests are: Mini-Mental State Examination
(MMSE), (Montreal Cognitive Assessment), Saint Louis University Mental Status (SLUMS) exam,
Geriatric Depression Scale (GDS), Functional Activities Questionnaire (FAQ) and Activities of
Daily Living (ADL) [5,7,15]. We will detail some of the screening tools in following chapters. Each
of these screens provides different psychometric properties, organization, and administration.
In other words, each one offers its own set of pros and cons. These tests warrant clinicians if a
person’s cognitive function need further testing. In the following sections, we will state some of
the concepts and terminologies that used in AD progression and prediction.

2.2 General Terminology
This section aims to introduce some general terminology and some AD biomarkers that
will be used in following chapters.

2.2.1 Clinical Dementia Rating (CDR)
The Clinical Dementia Rating is a scale that is used to evaluate the stage of severity of
Dementia, primarily for diagnosing Alzheimer’s. CDR is a five points scale where CDR=0 indicates
a person with no cognitive impairment, and the other four points are:
•

0 = Normal

•

0.5 = very mild dementia

•

1 = mild

•

2 = moderate

•

3 = Severe
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Six domains are used to construct the CDR, these domains are: Memory, Orientation,
Judgment and Problem solving, Community Affairs, Home and Hobbies, and Personal Care [16].

2.2.2 Mini-Mental State Examination
Mini-Mental State Examination (MMSE) is a multi-domain cognitive test that is used by
physicians to evaluate patients with cognitive impairment. MMSE is a 30-point screening
measurement that divided into 6 domains: orientation, concentration, attention, verbal
learning, naming, and VisuoConstruction (VC). However, MMSE evaluation for cognitive tests
can be influenced by age, education, language, and cultural background and can easily result in
the ceiling effect. The 30-point [17-21] score used to generate an assessment or diagnosis:
•

Score of 20-24: suggest mild dementia.

•

Score of 13-20 suggests moderate dementia.

•

Score of less than 12 indicates severe dementia.
MMSE has a good sensitivity (71 to 92 percent) and specificity (56 to 96 percent). It has

good sensitivity; 71 to 92 percent and specificity 56 to 96 percent. One of the core factors that
effects on the MMSE score is Educational Level. People with higher education scored high level
of MMSE.
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2.3 Montreal Cognitive Assessment (MoCA)
The Montreal Cognitive Assessment (MoCA) is a 30-question test that is used to help
assess people for dementia. It is a written test that takes 10 to 12 minutes to complete and
assesses multiple cognitive domains including memory, language, executive functions,
visuospatial skills, calculation, abstraction, attention, concentration, and orientation.
Different types of cognitive abilities assessed by MoCA:
•

Orientation

•

Short-Term Memory/Delayed Recall

•

Executive Function/Visuospatial Ability

•

Language Abilities

•

Abstraction

•

Animal Naming

•

Attention

•

Clock-Drawing Test
MoCA is used to detect subjects with MCI due to Alzheimer’s disease and to distinguish

them from healthy controls. In order to use MoCA to accurately identify and diagnose dementia,
the test should be paired with other screenings [21-23].
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2.4 Machine Learning Models
Machine Learning algorithm is a technique that learns from patterns in a data. It is a
computational model that aims to extract knowledge from data set by finding a relation
between input variables and associated.
Machine Learning algorithms can be classified into three categories. First category is
Supervised ML where the data has previously annotated. Examples would be Support Vector
Machines (SVM), k-nearest neighbors, Linear Discriminate Analysis. Supervised ML can be
further subdivided into Regression Analysis and Classification Analysis. The second category is
Unsupervised ML where the algorithm draws inferences from data sets consisting of input data
without using the outcome. K-means Clustering and Principal Component Analysis are examples
of Unsupervised ML. Lastly, Reinforcement ML, this type of ML aims to reward good behavior.
One of the massive success of reinforcement ML is Neural Networks, Q-Learning and StateAction-Reward-State-Action (SARSA). In the following sub sections, we will discuss some
machine learning that are related to our work [24,25].

2.4.1 Survival Analysis
Survival analysis can be defined as a set of statistical methods that used to analyze data
in which time until the event occurrence is of interest. The time, t, here often named as survival
time or event time, which can be years, months, weeks, days or even age. One of the terms that
consider in survival analysis is survival function S(t) which is given by:
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𝑆(𝑡) = 𝑃𝑟𝑜𝑏{𝑇 > 𝑡 } = 1 − 𝐹(𝑡),

(1)

where F (t) is the cumulative distribution function (c.d.f) for T. Therefore, S (t) is the probability
that a subject survives beyond time t.
Another important function is the hazard function λ(t), which can be defined as the
event rate at time t:
𝑡 < 𝑇 ≤ 𝑡 + 𝑢|𝑇 ≥ 𝑡
,
∆"→$
∆𝑢

𝜆(𝑡) = lim

(2)

where u is a small-time interval. Hazard function is the probability that a given subject will fails
in next small interval, u, conditional on having this subject survived to time t (T ≥ t). [26, 27].
Lastly, cumulative hazard function; H(t), is a measurement of the risk: the greater value
of H(t), the greater the risk of failure by time y

%

𝐻(𝑡) = E h(s)ds,

(3)

$

The previous three functions are used to describe the distribution of survival time.

2.4.1.1 Censoring
Censoring is one key analytical problem that considered in survival analysis. Censoring
occurs when we do not know the exact time for subject survival, but all what we know is some
information about that survival time. Put differently, either the event occurred and hence we
14

can find when it occurred, or it did not occur during the follow-up time, but we know the period
in which the event did not occurred [26, 28]. An attractive feature of survival analysis is that we
are able to include the data contributed by censored observations right up until they are
removed from the risk set. The following terms are used in relation to censoring:
•

Right censoring: a subject is right censored if the failure occurs sometime after the followup period.

•

Left censoring: a subject is left censored if the failure occurs sometime before the followup period.

•

Interval censoring: a subject is interval censored if the event occurs between two times,
but the exact time of failure is not known.
In figure 2.1 below some patients followed-up from 2005 until 2016 this is means they

have 12 records; others joined the follow-up study later. Another different case is depicted in
patient 10; the patient followed-up for three years (2009 until 2011) with missing one year 2010
(labeled with ? mark) but we do not know any information about this patient after that time.
Patients 2, 7 and 9 censored until 2016, taking to account that patient 9 followed-up just from
2014 until 2016 and patient 2 missed one screening in 2015 [26, 28-30].
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Figure 2.1 Types of point-censored observations. Built for 10 subjects from
UDS dataset

2.4.1.2 Cox Proportional Hazard Model
Cox in 1972 proposed a proportional hazards model called Cox model for survival data
analysis. It is semi-parametric model; a parametric assumption makes for the effect of
explanatory variables and no assumption makes for the nature of hazard function [26,27]. Cox
model can interpret the relation between hazard function and explanatory variables. This
relation can be mathematically written as:
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𝜆& (𝑡) = 𝜆$ (𝑡) × 𝑒𝑥𝑝(𝑋& (𝑡)𝛽& ),

(4)

where λ0(t) is the baseline hazard, X is a vector of explanatory variables and β is a vector of
regression coefficients. This explain the fact that even if the baseline hazard is unspecified, we
can estimate the regression coefficients from the exponential part. Cox proportional hazard
model frequently used in analyzing survival data due the fact that we do not need to specify the
probability distribution for the baseline hazard function [26-31].

2.4.2 Decision Tree
Decision tree, or recursive partitioning technique, is one of the most popular and
powerful approaches that used in classification and prediction and facilitating decision making
in sequential decision problems. Decision tree used in many disciplines such as statistics,
machine learning, pattern recognition. Decision tree provides a graphical model that can be used
to understand the problem and aid in decision making [32]. Generally, decision tree consists of
edges and nodes. Nodes in decision tree can be divided into:
1. Chance node: or sometimes called event node, this node shows the probability of certain
result. Each branch extended from chance node represents one of the possible events
that may occur at specific point.
2. Decision node: as the name implies, decision node shows decisions that can be made.
Branches that extended from decision node show all distinct options available at a node.
3. Terminal node: this node has no further chance or decision nodes, it considered as the
final outcome of the survival tree.
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One of the prominent recursive partitioning techniques is Classification and Regression
Tree algorithm (CART). Tree-based models provide logical and interpretable structure.
Moreover, it has the ability to detect complex interactions between covariates. Generally, in
tree-based models, the data is recursively partitioned based on a splitting criterion, and the
objects that are like each other based on the event of interest will be placed in the same node
[32-34]. Survival tree is one of decision tree variations. The main difference between traditional
decision tree and survival tree is in the splitting criterion. Splitting criterion is the way that how
to choose the splitting attributes.
Recently, survival tree received a great deal of attention in research field. Decision tree
used by [35] to model the survival data with competing risk. The researchers proposed a Survival
Classification and Regression Tree (SCART) technique to analyze survival data by modifying CART
algorithm to handle censored data for both regression and classification problems. The study
showed that SCART improve upon the existing classical method for analysis of survival data with
competing risks. Two types of competing risks trees used in a study by [36]. Event trees are
designed for analysis of the event of interest, while composite event trees are used for
competing events. Ensembles were built using these two different trees. The study depended
on nine real data and simulated data set. One conclusion from this study showed prediction
error of the individual trees and the other methods are similar, however the Cindex results differ
from the FineGray sub distribution hazard model and the FineGray regression with backward
elimination. Proportional hazards models in censored survival data proposed in a [37] research.
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The research developed a tree-based method for censored survival data, based on maximizing
the difference in survival between groups of patients represented by nodes in a binary tree.
In another study, [38] suggested using tree-based identification to identify subsets of
time- varying covariate risk factors that affect survival while adjusting for possible confounders.
The technique that was used in this study was developed from data from the Bypass Angioplasty
Revascularization Investigation 2 Diabetes clinical trial to find combinations of modifiable timevarying cardiac risk factors.
Time-to-event data has been modeled by [39] using classification tree analysis. By using
empirical data, the study showed that it is possible to identify all statistically valid, reproducible,
longitudinally consistent, and cross generalizable classification tree analysis (CTA) survival
models. This study concluded that the classification tree analysis survival model offered many
advantages over Cox regression. [40] proposed several methods for selecting one representative
model out of multiple decision trees induced from different slices of the same massive dataset.
The goal of this study was to overcome challenges for selecting one representative model for
big data and secured environments. A semantic approach called SySM that is based on a decision
tree structure was suggested. The suggested methods were applied to six different big
benchmark datasets.
The main reason for missing data in clinical trials is the participants who discontinue the
assigned treatment due to adverse event or lake of efficacy, [41] models the dependencies
among the clinical variables with Bayesian network used later for data imputation in order to
allow the decision tree to be applied on the complete dataset. The researchers concluded that
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Bayesian networks are a promising method to handle missing values especially in datasets
where the number of missing data is considerably high, and the number of samples are small.
The study also showed that by using Bayesian networks, patients can be divided into more
precise groups. A broad multifunctional decision tree used by [42] to predict dementia. The
study involved 75 various variables to investigate predictive factors for dementia and possible
prognostic subgroups. The study found out that most of the variables that selected by the
training tree were related to modifiable risk factor. As an accuracy, the proposed approach in
this study reached out 0.745 as AUC and 0.722 as recall for 10-years prognosis of dementia.

2.4.3 Functional Ensemble Survival Tree
One of the widely adopted ensemble tree method is Random survival forest (RSF). RSF is
an extension of Random Forest machine learning approach that is widely used to analyze rightcensored survival data and to build risk prediction model. RSF can be train on longitudinal data
covariates to learns from the available functional and baseline covariates in the cohort, such
that the model can be used to make risk predictions for new subjects conditioning on partially
observed data [43-45].
Random Forest use two randomization forms. First, the Random Forest tree grow by
randomly drawn bootstrap sample of the. Second, at each node of the tree, subset of variables
randomly selected as candidate variables for splitting. Survival data are often analyzed using
restrictive assumptions like proportional hazard, RSF brings a great value where the survival data
can be analyzed with no need to restrictive assumptions.
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As an alternative to survival analysis algorithms, RSF received a great deal of attention in
the literature. Researchers in [45], proposed using functional ensemble survival tree framework
to characterize the joint effects of both functional and baseline covariates to predict AD. The
study framework characterized the changing patterns of multiple time-varying neurocognitive
biomarker trajectories and then nest these features within an ensemble survival tree to predict
AD. The researchers in [46] showed that the splitting rules with the censored outcomes rely on
biased estimation of the within-node failure distribution. The researcher proposed new splitting
rile that compares bias-correlated cumulative hazard functions at each internal node.
Since Alzheimer’s disease considered a primary risk factor for cancer, [47] investigated
the probability of AD diagnosis from brain network and demographic and genetic data obtained from
47 female AD converters and 47 matched healthy controls. The proposed classifier was able to
discriminate between AD and CN with 86% accuracy on p<.0001. Furthermore, the researchers showed
that Chemotherapy-treated breast cancer survivors demonstrated significantly higher probability of AD
compared to healthy controls on p<.0001.

In a study that published in 2020, [48] proposed using Random Forest for survival for to
evaluate the prediction of censored data. In this study that applied on 8 age-related disease data
from English Longitudinal Study of Aging (ELSA), the researchers concluded that the proposed
Random Forest variant outperformed a well-known Random Forest variant for the censored
data. The researchers in [49] enhanced the predictive performance of RSF by a modeling
framework to incorporate multivariate longitudinal data in the model building process to
enhance the predictive performance of RSF. The proposed framework (functional survival
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forests framework) adopted two methods: multivariate functional principal component analysis
and multivariate fast covariance estimation for sparse functional data. The researcher, then,
used the features from previous two methods in the subsequent RSF model.

2.4.4 Recurrent Neural Networks (RNNs)
A Recurrent Neural Networks is a type of neural network where the neurons send
feedback signals to each other to inform the upcoming events. Simply put, RNN is series of
networks linked to each other to operate across a sequence of vectors. RNN’s powerful lies in
the use of feedback loops to process a sequence of data [50], see figure 2.2. These feedbacks
loops allow knowledge to be prolonged in trained network. Some of the most popular recurrent
architectures in use, including long short-term memory (LSTM) and gated recurrent units
(GRUs). For example, in LSTM networks, capture long-term temporal dependencies by dealing
with the exploding and vanishing gradient problem during backpropagation through time [51].
As explained earlier in the beginning of this chapter, longitudinal data (as seen in AD clinical
trials) often contain missing biomarker value due to, for example, study design, dropped out
subject, unsuccessful measurement, RNN cannot be applied directly. Preprocessing data to
handle missing values is needed before applying RNN. Among the most common methods that
used to handle missing data are data imputation and data interpolation.
RNN has critically influenced academic dialogue on several research fields. In the context
of medical field, there is a considerable amount of literature on using RNN in medical health
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record [52-55], Cancer detection [56-58], Heart failure [59-61] and AD progression [62-64] to
name a few.

Figure 2.2 General architecture of RNN

Experiment on predicting AD progression using RNN were conducted by group of
researchers in [62]. The researchers proposed a minimal recurrent neural network
(minimalRNN) to predict longitudinal data taking care of missing data. The study compared the
performance of the RNN model and three baseline algorithms up to 6 years into the future.
Three different strategies to handle missing data were tested. The study concluded that the RNN
with model filling was better than baseline algorithms, including support vector
machine/regression and linear state space (LSS) models. In another investigation, [65] trained
RNN to fill in the incomplete (missing) data. The proposed trained model applied on a data from
Alzheimer's Disease Neuroimaging Initiative (ADNI) database to model the monthly progression
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of Alzheimer's disease for seven years into the future which is a multi-step prediction problem.
The study concluded that proposed model outperforms baseline models.
One of the earliest attempts to utilize RNN on AD recognition was made by [66]. The
researchers designed and trained RNN to discriminate people with MCI and their age-matched
control subjects. In this study, the researchers combined RNN with Wavelet preprocessing and
they achieved the best result of training and testing with 3-layer RNN on left parietal channel
level 4 high-pass wavelet sub bands.
In [67] utilized RNN to address multiple biomarkers modeling that the parametric
assumptions cannot model. This study also considers uncomplete data issue. The study showed
a significantly lower mean absolute error (MAE) than the alternatives with p<0.05. It has been
suggested by [68] to combine convolutional (CNN) and recurrent neural networks (RNN) for
longitudinal analysis and this seems reliable approach. The study suggestion was as follow: CNN
is constructed to learn the spatial features of MRI, then RNN constructed on the output of the
CNN with three bidirectional gated recurrent unit layers. The researchers in this study achieved
classification accuracy of 91.33% NC vs AD and 71.71% for progressive MCI (pMCI) vs static MCI
(sMCI).

2.5 Conclusion
Detection and prediction of AD in early stages have been analyzed and discussed in this
Chapter. The chapter introduced some general terminology and biomarkers that will be used in
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next chapters. The previous related works have been categorized depending on the ML that have
been used.
As we noticed through the survey of the previous work, the main issue that researchers
are facing is the censoring data. Different methods and technologies have been used to overcome
this challenge. Some of the researchers choose to use the survival analysis, this
analysis/regression will take care of the missed (censored) data. Other researchers used preprocessing techniques to overcome the censored data.
Another observation that we noticed is that still the big challenge that the researchers
are facing is predicting the conversion from MCI to AD due the heterogeneity of MCI, however,
a good classification accuracy has been noticed in some works when the goal is to classify the CN
from AD.
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Chapter 3
Extended Cox Proportional Hazard Model to
Analyze and Predict Alzheimer’s Disease

3.1 Introduction and Background
The Mini-Mental State Exam (MMSE) is the most common tool that used to by clinicians
to help diagnose dementia and to help assess its progression and severity. The MMSE, or
sometimes called the Folstein Test or the Standardized Mini-Mental State Examination (SMMSE),
used to assess changes in a person who has already been diagnosed with dementia. The low score
on the MMSE is not a guarantee of Dementia or AD. Scoring MMSE is very straight-forward
process and can be managed by family member or loved ones, however it needs professional to
interpret the scoring. Previous studies pointed out that the MMSE is a poor predictor to identify
AD [69]. In spite of that, in this chapter, we propose to improve MMSE predictability by using a
combination of predictors with MMSE. We will test group of predictors and evaluate the effect
of each predictor on the accuracy of the prediction and classification process. Cox proportional
Hazard model (CPH) will be used to analyze the clinical NACC Uniform Data Set (UDS). Two
developed versions of Cox Proportional Hazard (COX) model will be used - Anderson-Gill (AG) and
frailty.
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3.2 Survival Analysis and Time to Event Data
Survival analysis is a collection of methods that known under different names. In
biostatistics it is often named survival analysis, in social science it is called event history, while it
is called reliability method in technical applications. Generally, in all previous mentioned filed,
one wants to model time to event data (TTE) [70]. Put another way, survival analysis used to
estimate the survival distribution, i.e., to compare two or more survival distributions to evaluate
the effects of a number of factors on survival. An important difference between survival analysis
and regression analysis is the outcome variable (time) is always positive and often censored [31].
In many medical studies, the outcome is TTE. The event can be death, occurrence of
disease, recovery from disease, injury. In this kind of studies, the interest not only whether an
event occurred or not, but also when an event occurred. In such studies the outcome variable is
compound of both an event and the time, therefore ordinary logistic and linear regression are
not suited to analyze such outcome. By the same token, ordinary regression methods cannot
effectively handle censoring observations; where the subjects do not experience the event
during the follow-up study time [28, 29].
TTE can be analyzed using three different approaches: non-parametric, semi-parametric
and parametric regression. Non-parametric approaches define TTE data with respect to factor
under investigation. In other word, analysis does not depend on an assumption about the shape
of the parameters in the underlying population. Instead, non-parametric approaches are used
to describe the data by estimating the survival function, S(t), along with the median and
quartiles of survival time. The most commonly non-parametric approach is Kaplan-Meier
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estimator. In medical researches, researchers interested to investigate the relation between
several covariates and time to event, in this scene, parametric and semi-parametric approaches
allow analyzing several covariates with respect to time to event. With semi-parametric model,
COX considered as the appropriate model for analyzing survival data. COX define the relation
between an event and a set of predictors (covariates). In Parametric model, the distribution for
outcome is specified. Accelerated Failure Time (AFT) is one of the parametric survival models
that used for estimating time-to-event data [26, 28].
In this chapter we proposed to use a combination of MMSE with other questionnaire
and demographic (Judgment, HomeHobb, Handed, Marriage status, Age, Sex, Race, Hispanic,
Level of education) data to be used as explanatory covariates. The main aim of this is of two
parts. First, what is the best combination of covariates that can be used to predict the conversion
of AD stages. Second, and while the previous studies showed that MMSE is poor predictor, what
are the covariates that can have an effect on MMSE predicating efficiency. For the second goal
we used one-level interaction between MMSE and each predictor in the suggested combination.
Two different COX model extensions; Andersen-Gill (AG) and frailty models were used in our
analysis.

3.3 Recurrent Events
Recurring events are same type events that happen more than once. In many healthcare
studies, event of interest occurs more than one time per individual, such events called recurrent
event. The recurrence includes multiple events of the same type or with different type that
naturally ordered in specific time sequence. Examples of such recurrent events include acute
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exacerbations in asthmatic children, accumulated cost analysis of medical care, multiple chronic
granulomatous infections, recurrent heart attack and recurrent of bladder cancer tumors. In all
previous examples there is a correlation between events in same subject that should be
considered. The main assumption in recurrent events is the assumption that the censoring time
is independent of the recurrent event process [70].
There has been a significant amount of discussion on methods for analyzing recurrent
events in different fields; biostatistics, epidemiological and medical literature. However,
inefficient or inappropriate statistical approaches are still used to analyze such type of data. The
Cox proportional hazards model is the most well-known approach that used to analysis of survival
data. Due to the independence assumption, the original Cox model is only appropriate for
modelling the time to the first event. In other word, Cox model is an appropriate for recurrent
events. Extensions of the original Cox model; ordered multiple event models or marginal
regression models, have been proposed for analyses of recurrent event data such as AndersenGill (AG) and frailty model [27, 29]. In previous chapter, we explained the Cox Proportional Hazard
model briefly. Following sections will introduce COX model and its variations, but before that we
will discuss one of the fundamental notations that used in survival analysis in this chapter and
next chapter.
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3.4 The Log Rank Test
The log rank test proposed in 1966 by N. Mantel that has long been a tool for comparing
survival curves. Log rank (or sometimes called log-rank) is a statistical test that formed by
using the following formula:

(Σ(observed events − expected events))'
𝐿=
,
𝑉𝑎𝑟𝑖𝑎𝑛𝑐𝑒

(1)

To better understand previous equation, let us consider the following example. Table 3.1
below, shows the number of people who died and the number of people who were at risk at each
time for which a death occurred. For group 1 we calculate how many deaths we would expect in
that group at that time if the two groups had identical survival curves.

Table 3.1: Log rank example for two groups
Group 1

Group 2

Total

Died

1

3

4

Survived

15

16

31

Total

16

19

35

Table 3.1 summarizes one of the death times from the collected data. The expected
number

of

deaths

in

Group

1

is

the

proportion

of

the

people

in

𝐺𝑟𝑜𝑢𝑝 1 𝑥 𝑡ℎ𝑒 𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑒𝑎𝑡ℎ (16/35) 𝑥 4 = 1.8). The value of variance in equation
1 above will standardize the value of 𝐿. The value of 𝐿 will be compared with the value that we
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should expect to get, larger value of 𝐿 will lead us to reject the hypothesis of equal survival in the
two groups [71,72].

3.5 Cox Proportional Hazard Model
The COX is a regression model that used for examining the association between the
survival time of individuals and one or more predictor covariates. In other words, COX model
used to evaluate the effect of several factors on survival simultaneously [26,70]. Having that said,
we can examine how specified factor(s) influence the rate (Hazard Rate) of a particular event
happening. The hazard ration then can be interpreted as:

•

HR = 1: No effect

•

HR < 1: Reduction in the hazard

•

HR > 1: Increase in Hazard

In COX assumption, the Hazard Rate is constant over time, meaning if an individual has a
risk at some initial time that is twice as high as that of another individual, then this risk will remain
twice all the time. The hazard rate is a probability that lie in the range 0 to 1, however, the hazard
represents the expected number of events per one unit of time. Consequently, a hazard in a
group could exceed 1 [26,28,70].
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3.6 Andersen-Gill model (AG)
AG model (or sometimes called the Proportional Intensity mode) is a model that extend
Cox proportional Hazard model to accommodate recurrent events in counting process. In this
model the correlation between events for a specific subject can be explained by previous events.
With AG model, each subject can experience multiple same type events where each subject
represented as a series of events with time interval as: (entry time, first time], (first time, second
time] …(mth event, last follow-up] [26]. In AG model the data from each individual is used up until
the time that the individual either experiences the event of interest or is censored. Consequently,
the parameters in AG model are estimated on the basis of a subset of participants that differs
from one time point to the next.

3.7 Frailty Model
Another extension for Cox model is the frailty model. Subjects in frailty models have
different frailties (random effects), and those who are most frail will die faster than the others.
The frailty models account for the heterogeneity in baseline hazard, whereas the hazard function
depends on an unobservable random variable. Different forms of frailty introduced in different
studies; shared, unshared, nested, joint and additive. Shared frailty model is the most commonly
used model, where subjects either clustered into groups or when recurrent event time clustered
for each subject [26, 73].
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3.8 Methodology
3.8.1 The National Alzheimer's Coordinating Center (NACC) Dataset
Data from the National Alzheimer’s Coordinating Center (NACC) Uniform Data Set (UDS)
were used. The UDS is a repository of prospectively collected data from different Alzheimer’s
Disease Centers across the United States supported by the National Institute on Aging. The
dataset of interest represents a follow-up study from June 2005 until November 2019. More
details information regarding this data set can be found in [74, 75].
Like almost all datasets, UDS dataset needs to pre-process in order to be used in the
suggested ML. The UDS has more than 500 features (covariates) that need to be filter. In our
proposed model, the feature vector has been built depending on two different sources. First, we
used L1 for feature selection to select the highest variance in the feature space that we have in
our dataset. Second, the previous list of features that we conclude from L1 discussed with our AD
expert; Dr. Niaz. Table 3.2 shows the covariates that we use to support the MMSE predictability.
In order to use this raw data in our suggested models we need to put this data in form
that can be processed. First, and as suggested by the experience, we included patients who aged
50 years or older because we interested to investigate the early stage of AD. Any subject that had
at least one MMSE screening included in the data set. Exclusion also includes patients that missed
one of the other questionnaire or demographic covariates. Once the above data preprocessing
executed, we will get a clean data set (n=44702 records for 11462 participants, that will be used
throughout our analysis. We interested to model data that indicates the conversion in dementia
stages, especially conversion from mild (early) stage to moderate (middle) stage. From this point
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of view, we can consider conversion in Clinical Dementia Rating (CDR) score from zero to any

No of Participant

other scale as failure time event that collected form failure time data; Figure 3.1.

year
Figure 3.1. Subjects of NACC dataset that have CDR > 0.5 vs. those have CDR <=0

Finally, data set divided into training and testing sets. Training dataset contains participants
who have been joined the study from 2005 to 2014 (n=41,635 records). The test data contains
participants who have been joined the study in 2015 to 2016 (n=3067 records).
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3.8.2 Implementation and Results
As mentioned earlier, NACC data set collected from several Alzheimer’s Disease Centers
across the United States, difference in the baseline risk might be a consider. Consequently, it is a
preferable to decide how many regression parameters will be used in regression model [26, 29].
Put another way, in case of multi enrolling centers, the limitation of fewer degrees of freedom is
desirable. In our case and with the number of enrolling centers we found that 17 is the best
degree of freedom that can be used with the regression models.
Time to repeated event explored using AG and frailty models. The models built using 10
variables; some of them are categorical variables; sex, race, marriage status while the other are
ordinal variables; MMSE, judgment and HomeHobb. Interaction between covariates and MMSE
also considered in this work in order to examine the factors that impact on MMSE as a predictor
for Alzheimer's disease. P-values (𝑃 < 0.05) used to test interaction significant.
Table 3.3 presents the two models with MMSE alone, with all predictors and the reduced
models. Using AG model, we can see that handed, sex and race are not significance covariates
(their 𝑃 − 𝑣𝑎𝑙𝑢𝑒 > 0.05), therefore ignoring these covariates will be consider in reduced model.
Add to this, and according to the interactions between covariates, AG model shows that the
following interactions should be considered:
•

MMSE with Judgment

•

MMSE with Age

•

MMSE with Sex

•

MMSE with Education
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Table 3.2.

UDS dataset statistics

Variable

Description

Details

MMSE

Total MMSE score

0-30 worst to best

Age

Subject’s age at visit

50 - 104 years

Handed

Subject’s age at visit

1=left-handed
2=right-handed
3=ambidextrous

Judgment

Judgment and problem

0= No impairment

solving

0.5 = Questionable impairment
1= Mild impairment
2=Moderate impairment
3= Severe impairment

HomeHobb

Home and hobbies

0= No impairment
0.5=Questionable impairment
1= Mild impairment
2=Moderate impairment
3= Severe impairment

Education

Years of education

0-36 years

Even if HomeHobb is a significant covariant but it does not have any interaction with
MMSE that is what AG says. From previous results we built a new AG model that ignores some
covariates and some interactions. The reduced AG model will contain MMSE, judgment,
HomeHobb, marriage status, Hispanic and education level and will consider interactions between
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MMSE and judgment, age, education level and sex. The reduced AG shown in Table 3.3 (column
4) labeled “Reduced AG”.
Not too much different, frailty model agreed with AG model results, but it has something
else to tell. Frailty model shows that covariates handed, marriage status and Hispanic are not an
efficient covariate and should not be included in reduced frailty model. The reduced frailty model
(that showed in Table 3.3 column 10 labeled “Reduced Frailty”) will include MMSE, judgment,
HomeHobb and education level and will consider interactions between MMSE and judgment,
age, education level and sex. Reduced AG shows an improvement (deceasing) in both AIC and
BIC, while reduced frailty model shows an increasing in both AIC and BIC. Graphically, Cox-Snell
residuals that presented in Figure 2 show that there is no preference between these two models.

3.9 Discussion and Conclusion
MMSE has been investigated by previous studies as an explanatory variable that can be used to
predict conversion to Alzheimer's disease since many previous studies have demonstrated that
MMSE is a poor tool in Alzheimer' disease predication. We proposed in this work to use MMSE
as a part of a group of predictors to improve the predication efficiency. AG and frailty models
were tested with NACC dataset to test which model is more suitable for such dataset and results
demonstrate that AG model is more suitable for the NACC dataset. Moreover, the two models
confirmed that a specific covariant is not effective as an explanatory variable; it’s possible to be
effective to improve the MMSE predictability.
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According to AG model MMSE can be combined with some predictors to improve
prediction of AD conversion efficiency. The results present judgment, HomeHobb, sex, handed,
marriage status, education level and Hispanic as a good combination of predictors. Moreover,
there is a strong relationship between MMSE and some other predictors. This may be answering
the question why MMSE is not good predictor if it used alone. Also, this confirms what previous
studies suggest; combine MMSE with other predictors. From AG result we can see that if MMSE
score decrease by one point this 64% will have a risk for decreasing in CDR score. Future
improvement to this work is to incorporate other predictors as explanatory variables or combine
the framework with another dataset to increase predication efficiency. Creating a model that has
high and early prediction ability is essential to give allowed for early on treatments and give the
patient to plan for life ahead.

Figure 3.2. Cox-Snell residuals for AG and frailty models
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Table 3.3. Comparison Between AG and Frailty Models with Just MMSE as a Predictor, With Group of Predictors Including
MMSE and Reduced Models
Frailty with
AG with MMSE

AG with group

Reduced AG

Frailty with group

Reduced Frailty

MMSE

Predictor
Hazard

Hazard

P-value

Hazard

P-value

Hazard

Hazard

P-value

Hazard

P-value

-1.19***

0.343

0.0001

0.365

0

-1.18***

0.394

0.025

0.796

0

Judgment

4.482

0.0001

4.307

0

3.644

0.0001

3.580

0

HomeHobb

1.603

0.0001

1.656

0

1.578

0.0001

1.598

0

Handed

1.037

0.049

0.945

0.018

1.067

0.534

Marriage State

0.978

0.0184

1.001

0.089

0.988

0.690

Sex

0.954

0.237

0.901

0.104

Education

1.007

0.0121

1.018

0.004

1.011

0.023

0.992

0.0392

Hispanic

1.175

0.013

1.369

0

1.163

0.152

Race

1.000

0.986

1.000

0.961

Age

1.001

0.674

0.991

0.015

MMSE: HomeHobb

1.093

0.145

1.063

0.601

MMSE: Judgment

2.546

0.0001

3.347

0

3.641

0

MMSE: Marriage S.

1.028

0.165

1.008

0.788

MMSE: Handed

0.897

0.121

0.914

0.433

MMSE: Age

1.015

0

1.016

0

1.018

0.0****

1.007

0

MMSE: SEX

0.805

0.0****

0.767

0

0.841

0.015

0.752

0

MMSE: Education

0.978

0.0002

0.965

0

0.950

0

0.956

0.0004

MMSE: Hispanic

1.200

0.2501

1.132

0.297

MMSE: Race

1.005

0.226

1.000

0.951

MMSE

2.804

AIC

110204.04

106633.50

106613.15

BIC

110308

106755

106739

*** 𝑃 − 𝑣𝑎𝑙𝑢𝑒 less than 0.001
**** 𝑃 − 𝑣𝑎𝑙𝑢𝑒 less than 0.0001
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Chapter 4

Modeling Big Medical Survival Data Using
Decision Tree Analysis with Apache Spark
4.1 Introduction
Massive amounts of data from longitudinal and extensive studies on thousands of
Alzheimer’s patients have been generated. There is a special interest in studying this data due to
a great potential hidden in it. Building a computational model that can predict conversion form
MCI to AD can be highly beneﬁcial for early intervention and treatment planning for AD [76].
Regression analysis of survival data has been widely used in real world problem. Although,
it has been documented that the regression analysis (proportional hazard model) does not always
provide suitable analysis of practical problems because of restrictive assumptions [26,77,78]. This
chapter seeks to address machine-learning big data model based on Survival Decision Tree to
determine the level of AD in a participant and predict the time of conversion to AD. The proposed
framework sheds new light on one of the widely used screening assessment for detecting
cognitive impairment called Montreal Cognitive Assessment (MoCA). MoCA data set was
collected from different centers and integrated into a big data framework storage using a Hadoop
Data File System (HDFS); the data was then analyzed using an Apache Spark framework.
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This chapter begins by examining the MoCA test. Next, we will review the big data
application in healthcare and how and where it can be fit. Survival Decision Tree (SDT) will be
used as a machine learning algorithm and will be introduced in next section. Also, this chapter
will do a comparison with the work we suggested in previous chapter (Extended Cox Proportional
Hazard model) and will compare the results from both models. Last section will present a
discussion and conclusion.

4.2 Montreal Cognitive Assessment (MoCA)
The Montreal Cognitive Assessment (MoCA) is an instrument that used to detect MCI in
patients with AD and other pathologies in cognitively impaired subjects who scored in normal
range on the MMSE. Previous studies [79-84] showed that MoCA has an excellent sensitivity and
specificity to detect subjects with MCI and distinguish them health controls. MoCA assessed
multiple cognitive domains including memory, language, executive functions, visuospatial skills,
calculation, abstraction, attention, concentration and orientation. Beside AD detection, MoCA
also is sensitive to detect cognitive impairment in Parkinson’s disease, Huntington’s disease,
brain tumors and more cognitive impairment disease [80].

4.3 Big Data: A brief introduction
Big data is massive and complex data that cannot be processed and handle by traditional
systems. Big data is characterized by Volume, Velocity, and Variety. Volume refers to the amount
of data; terabytes (1012 𝑏𝑦𝑡𝑒𝑠) to petabytes (1015 𝑏𝑦𝑡𝑒𝑠) and exabytes (1018 𝑏𝑦𝑡𝑒𝑠), are all
produced through different sources. Velocity refers to the speed at which data is generated and
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accumulated. Variety refers to all the structured and unstructured data that has the possibility of
getting generated. From previous definition of big data and its characteristics, health-care data
reaches the biggest data barrier [8, 40].
Storing, managing, and analyzing massive amounts of datasets are the main challenges
that are facing Biomedical scientists. Big data requires powerful and novel technologies to extract
useful information and enable more broad-based health-care solutions. With such diversity in
format, type, and context, it is difficult to merge big healthcare data into conventional databases,
making it enormously challenging to process, and hard for industry leaders to harness its
significant promise to transform the industry [85].

4.3.1 Apache Spark
Spark is an open-source project from Apache. It is one of the most commonly used
analytic engines for big data and machine learning. Spark is commonly used with the open-source
Apache Hadoop, but it also can be used with other data sources like MongoDB, Amazon3, and
Cassandra. Spark can ensure fast iterative access to datasets because it uses an in-memory
processing engine to allow data workers to efficiently execute streaming, machine learning or
SQL workloads. Spark has distributed and massive parallel computing capabilities that offers the
processing of datasets that traditional systems cannot. Spark can access several data sources like
HDFS, Amazon S3 (Amazon Simple Storage Service) or HBase. Moreover, Spark provides machine
learning algorithms, SQL and streaming data processing [40, 86].
As healthcare providers look for innovative ways to improve the quality of healthcare,
Apache Spark is slowly becoming the heartbeat of many healthcare applications. To give a clear
example, MyFitnessPal; the largest health and fitness community, uses Apache Spark to clean the
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data entered by users with the end goal of identifying high quality food items. Using Spark,
MyFitnessPal has been able to scan through more than 2.5𝑇𝐵 data of about 80 million users.

4.4 Survival Decision Tree
Tree-based methods were first developed to model the relation between
covariates and either a categorical or a continuous outcome. One of the popular tree-based trees
is the Classification and Regression Tree (CART) that introduced by Breiman [43]. In 1985, Gorden
and Olshen [87] presented Survival Decision Tree (SDT); an adaptation of CART to handle right
censored data. SDT is nonparametric machine learning algorithm that is flexible, easy to
interpret, can be extend to multiclass classification, handle categorical features, do not require
feature scaling and are able to capture non-linearities and feature interactions. Moreover, there
is no assumption needed about the underlying function for that SDT consider as powerful
algorithm that can be applied [88, 89]. Correspondingly, SDT require fewer assumptions than
classical methods and the assumptions about the underlying distribution of the data are not
required. Hence, SDT are becoming popular alternatives to linear regression and linear
discriminant analysis.
Generally, decision tree consists of nodes that form rooted tree with a node called root
connected with other nodes called leaves or terminal. Each node in the decision tree will test the
entries and will split it into two or more subspaces. The splitting process occurred by using
recursive if-then rules. The terminal node values in decision tree are a single value, whereas, in
survival tree, the terminal node value is a survival function, and the patient survival can be
estimated and evaluated using those terminal nodes.
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One key concept in decision tree is the impurity measure: how well n classes are
separated, in other words it measures the purity amongst children nodes. There are several tools
to measure the degree of impurity, the most well-known tools are entropy, Gini index and
Classification Error.
Generally, there are two types of splitting criterion. The aim of the first splitting criterion
is to minimize the risk within the node, while the other type aims to maximize the degree of
separation between nodes. There is no specific recommended splitting criterion for survival tree
that performs uniformly optimally under different situations. In survival tree, since the goal is the
comparison of survival distributions of two or more groups, one of the statistical tests that
commonly used is log-rank test that will be introduced in next section.
To best understand the idea behind the decision tree let us introduce some notations and
definitions. Suppose that ℎ is a node of a tree, and the task is to split it into two daughter nodes,
also let us assume that there are 𝑛 cases in the node ℎ. In case we have 𝑃 𝑓𝑒𝑎𝑡𝑢𝑟𝑒𝑠/𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒𝑠
(𝑐𝑜𝑛𝑡𝑖𝑛𝑢𝑜𝑢𝑠 𝑜𝑟 𝑐𝑎𝑡𝑒𝑔𝑜𝑟𝑖𝑐𝑎𝑙) in the dataset (𝑋(& , … , 𝑋&) ). If 𝑥 is 𝑐𝑜𝑛𝑡𝑖𝑛𝑢𝑜𝑢𝑠 variable, the split
of ℎ on 𝑥 will be always of the form 𝑥 ≤ 𝑐 and 𝑥 > 𝑐 where c is a split value. This split will create
two daughter nodes (𝑙𝑒𝑓𝑡 and 𝑟𝑖𝑔ℎ𝑡) according to an individual’s value 𝑋&) . In case that 𝑥 is
𝑐𝑎𝑡𝑒𝑔𝑜𝑟𝑖𝑐𝑎𝑙, the split process will be more complex. In this case, 𝑥will be treated as a factor with
immutable 1: 1 mapping of categories to integers. Thus, 𝑥 with 𝑓 categories are uniquely mapped
to 𝑓 integers {1, … , 𝑓}. Previous factor requires dividing the levels into two subsets: 𝑙𝑒𝑓𝑡 and
𝑟𝑖𝑔ℎ𝑡. If we have a factor with 6 levels in a node that has 𝐶 (6,1) + 𝐶 (6,2) + 𝐶 (6,3) possible
splits. These possibilities can be considered as three distinct groups:
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•

First group has the first group has one level going left, and five levels going right. There
are 𝐶 (6,1) such splits.

•

The second group has two levels going left and four levels going right. There are
𝐶 (6,2).

•

The third group has three levels going left and three levels going right. There
are 𝐶 (6,3).

The total number of possible splits (complementary pairings) is 2*+( − 1.
From what mentioned earlier, we can see a problematic issue of the large number of
permutations as the number of levels raise. Consequently, one of the limitations of SDT is that it
requires a lot of training data to estimate the mapping function. Also, it is slower to train because
it often has far more parameters to train [87]. In this chapter we aimed to apply a decision tree
to analyze big data on cloud to overcome previous limitations.

4.5 Log-Rank Test Score Split Criteria
As mentioned in previous chapter, the log-rank test compares the hazard functions of the
two groups at each observed event time and choose the largest log-rank statistic between the
two daughter nodes [37]. Generally, the idea behind log-rank test is to sum up the difference
between the observed and expected number of deaths and standardize it by its standard
deviation. Mathematically, log-rank statistics is:
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(𝑂 − 𝐸)'
𝐿𝑜𝑔 − 𝑟𝑎𝑛𝑘 𝑠𝑡𝑎𝑡𝑖𝑠𝑡𝑖𝑐𝑠 =
,
𝐸

(1)

where:
•

𝑂 is the total of observed events.

•

𝐸 is the total of expected events.

4.6 Methodology
4.6.1 Dataset Preprocessing
Data needs to be ready to work with; processing raw data may require extra
computational resources. To prepare the UDS in such a way that it could fit to our model, a
preprocessing process was needed. Data filtering was the first step; discard any data that is not
required in the prediction system and keep only the variables (predictors) that we want to feed
to the proposed framework. Second, and the most important in our work, was Missing Data
Management. Since our goal is to investigate the early stages of AD, subjects who were aged 50
years or older were included in the proposed model. Next, only subjects that had at least one
MoCA screening were included in the dataset. Exclusion also includes patients that missed one
of the other questionnaires or demographic covariant. The number of subjects in the data set
after previous filtering was 3956 subjects.
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Figure 4.1: Boxplot of the distribution of participant according to MoCA score

The resulting data set was divided randomly into training (3099 𝑠𝑢𝑏𝑗𝑒𝑐𝑡𝑠) and the rest
(875 subjects) was used for testing. Considering figure 2-B, we can see that most participants
falling in MoCA score between 23 and 30. This means that we need to take the advantage of
knowing the other participants (MoCA between 0 and 22) to predict the time of conversion from
one stage to another.

A

B

Figure 4.2: Histogram of participants ages (A) and participants MoCA score (B)
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Table 4.1. Formatting specifications
Covariant

Value

Detail

MoCA

Greater than 26
Avg of 22.1
Avg 16.2

normal controls
MCI
AD

Gender

1
2

Male
Female

Education Level

>= 12
16
18
20

High school/GED
Bachelor’s degree
Master’s degree
Doctorate

Hand

1
2
3
9

Left-handed
right-handed
Ambidextrous
Unknown

Table 4.2.
Subject
Category
CN
MCI
AD

Dataset statistics

MOCA

Count

Age

26.05
24.17
20.05

3281(1112/2169)
438 (261/177)
237(91/146)

73.46
77.03
81.35

Hand (L/R/A)
2943/266/73
61/371
16/217

Education
(year)
16.16
15.66
15.41

4.7 Implementation
The proposed framework consists of data storing and data analyzing using machine
learning algorithms. Our work depends on applying survival decision tree to analyze and predict
the conversion from MCI to AD.
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4.8 Data Storage
Dealing with large datasets is one of the challenges that traditional systems are not
suitable for. Big data systems can handle this challenge by storing large datasets in
𝐻𝐷𝐹𝑆, 𝑆3, 𝐻𝑏𝑎𝑠𝑒, MongoDB, etc. These storage components are scalable and fault tolerant;
storing faults can be handled by the process of replica creation; copying (replicating) the data
from one service to another and synchronizing the destination service dataset with the source
service dataset, based on a specified replication schedule [27,28].
Data storage infrastructure ensures the big data is sorted in such a way that it can easily
be accessed and processed by services working on big data. Also, Big data storage enables
flexibility of scaling [29].

4.9 Proposed Spark Framework
Amazon Web Service (AWS) was used as a cloud computing platform to build a cluster
that will be used to execute survival decision tree. A cluster in AWS is a logical grouping of tasks
or services. We used Elastic Compute Cloud (EC2) as a service to run the task. The cluster consists
of four nodes (EC2), one node is the Master node (Driver Program) while the other three are the
Core nodes, and this cluster can be easily scaled up or scaled down as needed. In the AWS cluster,
we can install different services depending on what task we want to execute on our data
(Machine learning algorithms, ETLs; Extract Transform Load, Streaming, etc). Since we wanted to
execute machine learning algorithms on our dataset, Spark with Spark MLlib were installed in this
cluster. Moreover, for data storage, S3 has been used to save the dataset, this storage can be
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used to store all the data that comes from screening centers. Scala is the programming language
that was used to write the machine learning algorithms. The resulting algorithm then was
executed as Spark job (Spark program) to be run on the EMR cluster. The results of classification
and prediction were saved in S3.

4.10 Results
4.10.1 Evaluation Criterion
To compare the predictive performance, Brier scores has been used. Brier score at time t for a
test sample 𝑁 can be defined as:

-

1
𝐼(𝑡, ≤ 𝑡, 𝛿, = 1)
𝐼(𝑡, > 𝑡)
𝐵(𝑡) = z {[0 − 𝑆}(𝑡|𝑥)]'
+ [1 − 𝑆}(𝑡|𝑥)]'
‚,
𝑁
𝐺• (𝑡, |𝑥)
𝐺• (𝑡|𝑥)

(2)

,.(

where:
•

t: given time point

•

N: test sample size

•

𝐺• (𝑡|𝑥) is the Kaplan-Meier estimate which represent 𝑃(𝑐 > 𝑡|𝑋 = 𝑥)

Another score can be used to evaluate the SDT and COX models is c-index (concordance
index). C-index is a simplification of the area under the ROC curve (AUC) that consider the
censored data. It represents the global assessment of the model discrimination power and has
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been considered as one of the most commonly used scores for survival models comparisons.
Simply, c-index can be calculated as:
𝐶 − 𝑖𝑛𝑑𝑒𝑥 =

𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑛𝑐𝑜𝑟𝑑𝑎𝑛𝑡 𝑝𝑎𝑖𝑟𝑠
,
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑛𝑐𝑜𝑟𝑑𝑎𝑛𝑡 𝑝𝑎𝑖𝑟𝑠 + 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑖𝑠𝑐𝑜𝑟𝑑𝑎𝑛𝑡 𝑝𝑎𝑖𝑟𝑠

(3)

As mentioned earlier, the variables that will be used in our model will be continuous and
categorical. For the continuous variable, MoCA and Age, the split candidates are typically the
unique values for the feature. Checking all possible split points p associated with continuous
feature components j may be computationally prohibitive [87,88]. In Spark, this implementation
computes an approximate set of split candidates by performing a quantile calculation over a
sampled fraction of the data [89].
From figure 3 we can see the prediction error for both SDT and COX models. The two
models yield similar prediction; however, COX regression model seems more extreme. Also, a
close look to figure 4; the c-index scores for both models, we can see that SDT outperforms the
COX model in prediction performance of survival. Another point to mention here is that the
fluctuation (up and down) that we can see in the COX model is due the assumption that this
model makes when it performs the prediction. Generally, SDT showing the most accurate method
for predicting survival outcomes over time.
The root of the survival tree contains all 2798 participants (4881 𝑜𝑏𝑠𝑒𝑟𝑣𝑎𝑡𝑖𝑜𝑛). The most
influential predictor that determines the stage of participants is MoCA as shown in variable
importance score; figure 5. In general, the survival decision tree shows low cost of classification
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for all three different stages of the participants. The classification tree that shown in figure 4
introduced the following:
•

Each branch is a decision for splitting the data into a new classification.

•

The decision tree split the data into three dementia stages (Normal, MCI and AD).

•

Generally, the survival decision tree shows a better classification accuracy than Cox model
with less cost.
Figure 6 and Figure 7 show the fitted Survival Tree for MoCA with Education Level and

MoCA with Hand respectively. In these figures, the survival tree displays the levels of the
variables used for classification at each node. The root node: MoCA, represents a decision based
on its value; the left branch corresponds to 𝑇𝑅𝑈𝐸 and the right branch 𝐹𝐴𝐿𝑆𝐸; greater than 25.
We can see that same variable can be used in next level of classification. The terminal nodes
(leaves) indicate the prediction for that partition and number who has Normal, MCI or AD out of
the total in that subgroup.

Figure 4.3: Prediction errors comparison for SDT and COX models
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Figure 4.4: Comparison of c-index for both SDT and COX models

Figure 4.5: Feature importance plot

As a classification task, figure 8 presented the SDT as a classifier. The SDT model showed
the lowest cost of classification comparing with COX model for almost all misclassification costs.
In addition, SDT enhanced its classification dominance relative to COX model as the prediction
interval increased.
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Figure 4.6: Fitted survival tree for participants with MoCA and education

Figure 4.7: Fitted survival tree for participants with MoCA and hand
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Figure 4.8: Classification tree for participants using MoCA, education level, gender and hand

4.11 Conclusion
Decision tree is a supervised machine learning algorithm that is used for classification and
prediction and can be applied on categorical and continuous variables. The main idea of the
decision tree is to split the sample into two or more homogeneous sets based on the most
significant splitter in input variables. This paper introduced a big data framework for modelling
clinical data using Survival Decision Tree. The framework offers an advantage over using Decision
Trees in a traditional system. The primary limitation of decision tree in traditional system is that
it requires a lot of training data to estimate. Another general limitation that it is slow since it
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often has more parameters to train. The proposed framework suggests using big data parallel
processing to overcome the previous limitation. Another advantage that is offered by this
framework is that data can be accumulative, and this makes the prediction part of this framework
more precise. Thus, as much data as we can feed our system the higher the accuracy we can get.
Additionally, non-parametric decision trees introduce accurate predictions without the
risk of violating statistical assumptions. Creating a model that has both high and early prediction
abilities is essential to allow for earlier on treatments and to give the patient improved quality of
life. Future improvement to this work will be to combine more datasets to increase prediction
efficiency. Another future work can be using Random Survival Forest (RSF) and compare the
accuracy of the applied survival tree.
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Chapter 5
RESEARCH ARTICLE Open Access

Predicting Future Alzheimer’s Disease Test
Scores with a Recurrent Neural network
5.1 Introduction
Mild cognitive impairment (MCI) is an intermediate stage between the normal cognitive

and the more serious decline of dementia. MCI is heterogeneous and previous studies showed
that not all MCI patients convert to AD [4,5]. Consequently, differentiating between MCI that will
develop to AD and those who will still stable (or may revert to normal cognitive) is one of the
challenges that considerable number of researchers have been followed. To that end, building a
computer system that enable early prediction of the conversion from MCI to AD is essential to
prevent AD progression [4,80,83].
In this chapter we will consider building recurrent neural networks; longshort-term
memory network (LSTM) and Gated recurrent Unit (GRU) on longitudinal dataset to predict future
AD test scores. We will discuss how we can build a machine learning using LSTM and GRU to
predict future MMSE and MoCA scores. In other word, we want to predict the indictor (predictor)
that clinicians usually using to indicate the cognitive of individuals. The chapter will be structured
as follow: Recurrent Neural Network (RNN) will be discussed with focusing on the LSTM and GRU
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networks. We will describe the dataset that will be used in this chapter in next section. Lastly,
the accuracy of all applied machine learning algorithms will be evaluated in a comparative section
with discussion.

5.2 Recurrent Neural Network and its Variations
A recurrent neural network is a neural network that has a memory-state neuron. It is
called recurrent because RNN performs the same task for every element of a sequence
depending on the previous computations. The memory-state neuron allows the network to
learn long-term dependencies in a sequence, meaning that the entire situation will be consider
when we make a prediction [90,91]. General speaking, instead of looking to the current
presented value, RNN will also consider the previous value, as shown in the Figure 5.1 below.
Formally, given a sequence 𝑥 = (𝑥( , 𝑥' , … , 𝑥/ ), the hidden layer ℎ0 state will be updated as:

ℎ0 = †

0,
𝜎(ℎ0+( , 𝑥0 ),

𝑡=0
𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒

(1)

where 𝜎 is a nonlinear activation function that used to define the output of each cell. The output
from Eq (1); the hidden layer, will be applied as:

ℎ0 = 𝑔(𝑊𝑥( + 𝑈ℎ0+( ),

(2)

RNN produces a probability distribution 𝑝(𝑥( , … , 𝑥/ ) where:
𝑝(𝑥( , … , 𝑥/ ) = 𝑝(𝑥( ) 𝑝(𝑥' |𝑥( )𝑝(𝑥1 |𝑥( , 𝑥' ) … 𝑝(𝑥/ |𝑥( , … , 𝑥/+( ),
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(3)

Despite its powerful, RNN fails to learn in the presence of time pauses greater than 5-10
discreate time steps between relevant input events and target signals. In fact, it is a big challenge
to propagate all this information when the time step is too long, especially when the network
has too many deep layers. The previous mentioned challenge called Vanish Gradient problem.
Two of the well-known RNN variation are LSTM and GRU that have been built to solve the Vanish
Gradient problem [91].

Simple Feed Forward Neural Network
Input

Hidden

Output

Recurrent Neural Network

Input

Hidden
+
Previous

Output

Figure 5.1 Simple feed forward neural network vs recurrent neural network

5.2.1 Long Short-Term Memory (LSTM)
The main idea behind LSMT is that it provides to the network relevant past information
to more recent time. Consequently, LSTM can learn to bridge minimal time lags in additional of
100 discrete time steps by enforcing constant error flow through Constant Error Carousels (CECs)
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within special units called cells [90, 92]. The computational unit in LSTM (or simply the cell) is
comprised of weights and gate. The cell’s weight has the following parameters:
•

Input weights: used to weight input for the current time step.

•

Output weights: used to weight the output from the last time step.

•

Internal state: used in the calculation of the output for this time step.

The cell’s gates are:
•

Forget gate: decides what information to discard from the cell.

•

Input gate: decides which values from the input to update the memory state.

•

Output gate: decides what to output based on input and the memory of the cell.
These gates influence the flow of data through the model, allowing it to pass information

to another time step only when it is relevant [93]. Moreover, this will make the memorizing
capability of the cell more intelligent and durable.
Contrasting with RNN which applied nonlinear function on weighted sum of the input
2

2

signal, LSTM maintains a memory cell 𝑐0 at time t. The activation, or the output ℎ0 of the LSTM
is:

2

2

2

ℎ0 = 𝑜0 tanh‹𝑐0 Œ,

(4)

2

where 𝑜0 is the output gate. Also, the output gate can be computed as:
2

𝑜0 = 𝜎(𝑊3 𝑥0 + 𝑈3 ℎ0+( + 𝑉3 𝑐0 )2 ,
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(5)

Updating the memory cell can be done in LSTM by forgetting the existing memory and
adding a new memory content:

2

2 2

2 ~2

𝑐0 = 𝑓0 𝑐0+( + 𝑖0 𝑐0 ,

(6)

Having the new memory content, LSTM unit is able to choose whether to keep the existing
memory via the introduced gates. Figure 5.2 presents the RNN, LSTM and GRU network
architectures. In this figure we can see that the cell in RNN takes input, 𝑥𝑖, and outputs the
current hidden state, hi, passing this to next RNN cell. However, the cell in LSTM is more
complicated, the “forget gate” takes the previous output ℎ0+( and the current input, xt, and
applies a sigmoid activation (σ) to get values between 0 and 1 for each hidden unit. This is
followed by element-wise multiplication with the current state. The “update gate” then updates
the state based on the current input. This passes the same input (ℎ0+( and 𝑥0 ) into a sigmoid
activation and into a tanh activation (tanh) and performs element-wise multiplication between
these two results. Next, element-wise addition is performed with the result and the current state
after applying the “forget gate” to update the state with new information [55, 90-94].

5.2.2 Gated Recurrent Unit (GRU)
GRU was proposed by Cho in 2014 [95], to make each recurrent unit to adaptively capture
dependencies of different time scale. Like in LSTM, GRU has cell’s gate to control the flow of
2

information inside the unit with no memory cells. In GRU, the output ℎ0 at time 𝑡 is a linear
2
2
interpolation between the previous activation ℎ0+( and the candidate activation ℎ•0 :
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2

2

2 2

ℎ0 = (1 − 𝑧)ℎ0+( + 𝑧0 ℎ•0 ,

(7)

2

The update gate, 𝑧0 , then can be computed by:
2

𝑧0 = 𝜎(𝑊5 𝑥0 + 𝑈5 ℎ0+( ) 2 ,

(8)

The update gate helps to determine how much of the past information needs to be passed along
to the future. Therefore, GRU eliminate the vanishing gradient problem because the model can
decide to copy all the information from the past [94,96].
In summary, both LSTM and GRU were created to overcome the vanishing gradient
problem. The main idea was to regulate the flow of information with internal mechanism called
gates. Having gates, LSTM and GRU can learn which data is important to keep and which data is
to throw. Previous process can be done on recurrent neural networks.

5.3 Dataset Description and Preparation
The dataset that we are using in this chapter is the Uniform Data Set (UDS) that provided
by National Alzheimer’s Coordinating Center (NACC). This data set collected since 2005 during
standardized annual evaluations conducted at the NIA-funded Alzheimer’s Disease Research
Centers (ADRCs). It is available in three different versions (v1.2, v2, and v3).
As we stated in chapter two, MMSE code falls in three ranges (20-24 indicates mild
dementia, 13-20 indicates moderate dementia, and less than 12 indicates severe dementia). The
dataset has some other special codes that represent special situations (Physical problem, Verbal
refusal, etc), for more details regarding the details codes please refer to [97]. Categorical
variables were converted using one-hot encoding. Handling missing data is the next step that we
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need to consider, to do so, we tested different options after separating that dataset into training
and testing datasets: Constant value within the record domain (Const), Mean, Regression, Min,
Max, K-nearest neighbors, Markov Chain Monte Carlo (MCMC), Expected Maximization Methods
(EMM).
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Figure 5.2 RNN, LSTM and GRU architectures
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5.4 Experiments and Evaluations
Figure 5.3 presents the architecture of the proposed model. LSTM and GRU have been
tested on more than 44,702 different entries that represents 11,462 individuals. The dataset
has been divided into 80% (𝑛 = 35,761) for training and 20% (𝑛 = 8940) for testing. Training
set has been divided into 80% for bootstrap training (𝑛 = 28,609) and the rest; 20% (𝑛 =
7152) for validation.
Initially, to determine the structure of the deep learning model, we need to set different
factors (the type of layer, the number of layers, the number of nodes in each layer) that effect
on the performance of the proposed model. After several trails, our model built on 1000 nodesthree hidden.
Next, we need to determine two important factors in the deep learning model, those are
the learning process optimizer and the loss function. Optimizers play a very crucial role in model
accuracy. One of the well tested and used optimizer is Adam optimizer that has been adopted in
our models. In deep learning the error for the current state of the model must be estimated
repeatedly, this requires the choice of error function or sometimes called loss function. Different
loss functions available, we used Mean Squared Error Loss function.
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Figure 5.3 The main structure of the proposed model. Different
observation and prediction windows were proposed

Additionally, to train the models there are different factors that we need to set:
1. The number of lookbacks: the number of states we use from the past to predict the future.
We set this factor as 𝑝 that we can control depending on the need. For instance, if 𝑝 set
to 3 this means that we look to times 𝑡 − 3, 𝑡 − 2 and 𝑡 − 1 to predict the outcome in
time 𝑡.
2. The learning rate: unlike other factors, this factor needs to be determined prior to the
commencement of the learning process. It controls how much to change the model in
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response to the estimated error each time the model weights are updated. In other
words, it controls how quickly or slowly a neural network model learns a problem. After
several training we set the training rate to 0.001.
3. The batch size: this factor controls the number of training samples to work through before
the model’s internal parameters are updated. According to [98], choosing large batch size
will leads to significant degradation in the quality of the model. We set batch size to 200
sample.
4. The number of epochs: this factor controls the number of complete passes through the
training dataset. We set the epochs to 100.

Srivastava el al. [99] in his work proposed to add dropout to one or more layers in neural network
to make each hidden unit in that layer more robust. Meaning, unit in a layer will rely on other
hidden units to correct its mistakes.

5.5 Model Performance Evaluation
To assess the model performance, ROC curve, MAE and RMSE score were used. ROC is a
curve that used to measure the performance for predictive models at various thresholds settings.
In details ROC curve used to measure as probability curve through set of functions between the
true positive rate and false positive rate; Table 5.1. The true positive rate is also referred to as
sensitivity. It describes how good the model is at predicting the positive class when the actual
outcome is positive. Mathematically it is:
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𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 = 𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 / (𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 + 𝐹𝑎𝑙𝑠𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠)
The false positive rate also called specificity, summarizes how often a positive class is predicted
when the actual outcome is negative.
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 = 𝑇𝑟𝑢𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠 / (𝑇𝑟𝑢𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠 + 𝐹𝑎𝑙𝑠𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠)
where 𝐹𝑎𝑙𝑠𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑅𝑎𝑡𝑒 = 1 − 𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦
Table 5.1. Confusion matrix

The MAE score used to estimate the average magnitude of the errors in a set of forecasts,
without considering their direction. The MAE can be calculated as:

𝑀𝐴𝐸 =

6
1
z |𝑦 − 𝑦•|,
𝑀
&.(

(9)

where 𝑦 is the actual value and 𝑦• is the estimated value.
The RMSE represents the sample standard deviation of the differences between predicted values
and observed values (prediction error). Meaning, it tells how concentrated the data is around
the line of best fit. Mathematically:
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#

𝑅𝑀𝑆𝐸 = '

1
1
* (𝑦! − 𝑦.! )" ,
𝑛
𝑛

(10)

!$%

RMSE usually used in regression analysis and machine learning to verify the experimental results.

5.5 Results and Discussion
The proposed RNN model assesses MMSE score(s) of individuals to predict the next score.
Two different RNN variation have been tested and evaluated; LSTM and GRU. The proposed
model results compared with three baseline models. The first two models were COX proportional
hazard model and Survival Decision Tree model that have been discussed in chapter three and
chapter four respectively. The third model was Support Vector Machine (SVM). The model tested
different time intervals for observation and prediction; Figure 5.4.
Feature selection: feature selection is a method that used to reduce the number of input
variables (features) to those that are believed to be most useful to the proposed model. In our
proposed model, the feature vector has been built depending on two different sources. First, we
used L1 for feature selection to select the highest variance in the feature space that we have in
our dataset. Second, the previous list of features that we conclude from L1 discussed with our
AD expert; Dr. Niaz. In total, we select 24 features that decided to feed to or proposed model
(see Table 5.2). The weights were generated using Glorot (Xavier) initialization scheme. The main
idea of Glorot initializer is to initialize small gaussian values with mean equal to 0 and variance
based on the fan-in and fan-out of the weight:
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𝑉𝑎𝑟(𝑊) =

2
,
𝑛&7 + 𝑛3"0

(11)

where 𝑛&7 is the number of neurons feeding into the network and 𝑛3"0 is the number of neurons
the result is fed to [94].

Figure 5.4 Different observation and prediction windows have been
adopted in the proposed model

Table 5.2 UDS dataset variables description
Variable Name

Description

Variable Name

Description

CDR
Age*
TI**
SEX
RACE
PRIMLANG
EDUC
NACCLIVS
INDEPEND
MARISTAT
HANDED

Global CDR score
Subject’s age
Time Interval
Subject’s sex
Subject’s race
Primary Language
Years of education
Living Situation
Level of Independent
Marital Status
Left, right, or Ambidextrous

WEIGHT
BPSYS
BPDIAS
HRATE
VISION
HEARING
MEMORY
ORIENT
JUDGEMENT
HOMHOBB

Subject’s weight (lbs.)
Subject’s blood pressure, systolic
Subject’s blood pressure, diastolic
Subject resting heart rate
Is the subject’s vision functionally normal?
Is the subject’s hearing functionally normal?
Memory
Orientation
Judgment and problem solving
Home and hobbies

*Age has been derived from BIRTHMO and BIRTHYR
**Time interval has been derived from VISITMO, VISITDAY and VISITYR

In addition to the input and output layers, there are two fully connected hidden layers in
the proposed RNN, each layer has 200 unit, with sigmoid function and to prevent overfitting, our
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model adopts 20% as a percentage for dropping out. Additionally, a cross validation with 10-fold
used in this model. The training process repeated 10 folds, where the performance of the model
will be the average of the 10 folds results. The final step is output normalization, to normalize
the network output, we used softmax function such that we have a vector of values between 0
and 1 that can be interpreted as probabilities. Generally, the softmax formula is:

𝑒 5'
𝜎(𝑧⃗)& = 9
,
∑2.( 𝑒 5 (

(12)

Where:
•

𝑧⃗:

•

𝑧 " : current input value that can be real value, positive, negative or zero.

•

𝑒 # " : Exponential function that will applied to all elements in the input vector.

•

##
∑$
: normalization function.
%&' 𝑒

•

𝐾: number of classes in the input vector.

the input vector to the softmax function

Another factor to mention here is choosing the best learning rate. To achieve the best
learning rate that will not lead to high fluctuation (high rate) neither slow converging (low rate),
we check different rates, and we record and plot the learning rate with the training loss. As we
can see in Figure 5.5, the best learning rate that we reached (the fastest decrease in the loss
function) was between 0.01 and 0.001. Consequently, we started with 0.01 and then decreased
the rate with small percent for each batch (until we reach 0.001).
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Figure 5.5 Training rate selected by drawing the learning rate vs the loss. The loss
decreases in the beginning of the learning the training process starts diverging

As we mentioned earlier, different dropout percentages have been tested as shown in
Table 5.3. Clearly, we can see that applying dropout to the RNN will improve the efficiency of the
model, our results indicated that 40% is the best percentage to do the dropout at.

Table 5.3 Descriptive statistics for applying different dropout percentages in the proposed model

0%
20%
40%
60%

count
40
40
40
40

Mean
97.5781
89.4482
88.9573
89.8112

std
8.12744
5.70723
4.09016
4.04678

min
84.7497
81.3153
80.6624
84.3005

Q1
91.52196
84.91106
85.88580
87.61691
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Median
97.32411
88.10965
88.79002
89.55591

Q3
101.2584
93.64254
91.51514
91.10456

max
125.618
104.548
96.3442
98.6801

One last thing that we need to check before we compare our model with the baseline
models is to choose the appropriate approach that we will use to deal with the missing data. As
we mentioned earlier different approaches are available to handle the missing data. For this end,
Table 5.4 and Table 5.5 presented a comparison between the different approaches to handle
missing data with the two different learning rates that we concluded from previous step: 0.01
and 0.001. We can see that K-nearest neighbors shows best results, so we adopted it in our
model.

Figure 5.6 Different dropout percentages and statistics

Table 5.4 Applying different approaches to handle the missing data. Results showing for both LSTM and GRU.
Learning Rate = 0.01

Const
Mean
Regression
Min
Max
KNN
MCMC
EMM

ROC

LSTM
MAE

RMSE

81.56

78.03

70.91

78.21
80.29
71.65
72.88
82.23
80.91
76.91

70.19
69.45
76.50
79.71
65.39
66.61
70.38

71.15
69.32
79.54
78.43
67.95
67.90
68.95
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ROC

GRU
MAE

RMSE

80.08

79.54

70.76

76.97
80.71
68.90
67.01
81.01
79.21
79.09

70.47
69.09
83.37
81.14
67.43
67.39
68.40

71.94
70.90
80.21
79.02
67.88
67.91
69.81

Table 5.5 Applying different approaches to handle the missing data. Results showing for both LSTM and GRU.
Learning Rate = 0.001

ROC
82.06
79.22
80.34
72.65
73.81
83.19
81.21
78.52

Const
Mean
Regression
Min
Max
KNN
MCMC
EMM

LSTM (LR=0.001)
MAE
77.23
69.79
69.16
75.49
78.52
62.64
65.31
70.18

RMSE

ROC

70.73
70.43
69.12
78.34
77.93
65.76
67.03
68.35

80.12
77.73
79.28
69.39
70.01
81.01
80.25
79.89

GRU(LR=0.001)
MAE
75.54
70.01
68.61
80.37
79.34
67.13
67.37
67.89

RMSE
70.02
70.19
70.34
79.43
77.65
67.88
67.58
68.01

Table 5.6 below presents the performance comparison of the proposed model and the
baseline models. The LSTM shows the superiority when it compared with other models. Also, it
is worth to mention here that the results of GRU was so close to the one that we get from LSTM.

Table 5.6 Comparison between proposed model with baseline models

ROC
MAE
RMSE

SVM

SDT

COX

78.98
84.21
85.54

79.91
88.54
89.27

81.01
88.11
89.76

LSTM
LR= 0.01
82.23
65.39
67.95
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GRU
LR= 0.001
83.19
62.64
65.76

LR= 0.01
81.01
67.43
67.88

LR= 0.001
82.18
64.01
65.76

5.6 Conclusion
In this chapter we presented two different RNN variations; LSTM and GRU. After testing
different learning rates, we decided to test our model with different learning rate (0.01 and
0.001). The we started with 0.01 and gradually decrease this rate until we reached the 0.001.
Cross validation with 10-fold has been adopted. Also, and to handle the missing data that our
data already has, we tested several missing data approaches, and we conclude that the KNN is
the best fit approach that we can use to handle this issue. Moreover, and to overcome the
overfitting problem, different dropout percentage have been verified and we concluded that
40% is the best dropout percent that we can use in our model. The developed model then
compared with different baseline models from previous chapters (COX model and SDT) and with
SVM.
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Chapter 6
RESEARCH ARTICLE Open Access

Conclusion, Future Work and Perspectives
6.1 Overview
This chapter will provide our conclusion, future works and perspectives. We will discuss

what are some challenges that we were met and what were our suggestions to overcome them.
The chapter will be divided into the following sections. First, we will go through the research
questions that we introduced in chapter one and discuss we cover. Next, we will go through some
future works for further development and enhancing.

6.2 Research Questions Review
In this section we will review the three questions that we commenced in the first chapter.

1) “Using clinical data, to what extent can a classifier classify subjects?”
Clinical data can be classified using different machine learning classifiers. However,
depending on the nature of the clinical data, not all data classifiers can fit to all
datasets. Our experiments show that almost all the longitudinal data suffer from
censoring, hence, to classify such datasets, a classifier that support survival analysis;
COX model and SDT, work very well. To add more, we found that the SDT, is the best
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classifier that we can use to classify longitudinal data. Also, in the same perspective,
we want to emphasis on that even in SDT, not all splitting criterions give the same
accuracy. We found that log-rank is one of the best splitting criteria that we can with
SDT.

2) “Can we build a predicator that can predict the time of conversion?”
Different predictors have been tested in different projects that we carried out in this
thesis. We found that RNN is a good machine learning that can be adopted to address
the conversion from one the AD stage to another. Different versions of RNN can be
used in order to achieve high accuracy system.

3) “With the medical and health data reached massive volume, to what level we can
involve Big Data technologies to our previous research questions?”
Here is an interesting challenge that we faced. As we found from answering the first
research question, SDT is a good classifier that can be used in linguodental dataset,
however, the main challenges that we faced with SDT was the time and complex
computing that needed to build the SDT. To overcome this previous challenge, we built
the SDT with big data technology. From this experiment we found that we can utilize
parallel processing system to process large dataset.
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6.3 Future Works
In this section we will introduce possible future work that can be devoted to improving
computational efficiency and computational accuracy. The suggested future work will be divided
according to the different machine learning that we applied in this thesis. that introduced in this
thesis can be improved in several ways:
1. Cox Proportional Hazard model can be improved by considering risk factors and
expanding more predictors into the suggested framework would, possibly, brings more
accuracy. We suggest adding more screening covariates to the model and test the
accuracy of the resulted model with the suggested model. Also, the model can be
modified to include MOCA score instead of MMSE. Another work that can be done in
this context is to use the suggested model to predict the next screening score; MMSE,
MOCA, etc. This will, for sure, helps the clinicians to further understand the long path
for their subjects. Add more scales/scores (Geriatric Depression Scale GDC; Functional
Activities Questionaries FAQ) to the suggested framework will be a good further work.
2. With SDT there are open doors that other researchers can try. The applied log-rank
splitting criteria can be revised, and the developed log-rank [95] can be used. Another
open area here is the type and number of variables that can be consider in each node
of SDT. Another possible work that can be done would be different node sizes and
number of trees. Additionally, and to better understand and estimate the
characteristics of the subjects, sampling methods can be used to recognize different
implementations and how they effect on prediction accuracy and performance. Also,
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as we suggested to improve the COX model, GDS and FAQ can be used to improve the
SDT performance.
3. In RNN model, different further works can be applied. One can applied LSTM and GRU
network as a first and second layer in the full network. Another variation of LSTM
(BiLSTM; Bidirectional LSTM) can be used and tested in the framework that we
suggested in chapter 5. Also, other information (variables) can be incorporated to the
LSTM/GRU network for further enhancement in both classification and prediction.

6.3 Perspective
In all three experiments, we see that the effective of currently screening tools (MMSE,
MoCA, etc.) can be increased by using Machine Learning algorithms that can take the effect of
those tools with some other features. From the Classification perspective we noticed that
Survival Decision Tree depends heavily on the screening tools and the other features used for
farther classification. We also noticed that RNN algorithm despite it over heading the other
algorithms, it fails in the learning time, which might be a good experience to run this algorithm(s)
in parallel processing manner such that we can resolved the learning time issue.
From Prediction perspective, the interpretation of the coefficients in COX proportional
hazard model is not straightforward when we compare it with Survival decision tree, and it is only
possible to examine the effect of a variable visually. Consequently, using Generalized Cox
proportional hazard model would be an interesting option, however one should time and sample
size into account when considering this option.
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